(Q45710740)

English

Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus

scientific article published on November 1, 2003

In more languages
default for all languages
No label defined

No description defined

Statements

Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus (English)
Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus (English)
0 references
Christophe Lurquin
Nicolas van Baren
Thierry Connerotte
Véronique Corbière
Marie-Ange Demoitié
Danielle Liénard

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit